Named on one round in the feed.
Since 2019-06-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Encoded Therapeutics Encoded Therapeutics develops gene therapies targeting genetic disorders, primarily focusing on neurological conditions. | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $104M | 2019-06-26 | [ PART ] |